Partner, Patent Attorney London
Profile of Kirk Gallagher

I’ve been a partner at D Young & Co since 2004. Turning complex, contentious cases into winning ones is the most rewarding part of my role. I particularly enjoy presenting cases at EPO oral hearings. 

Since joining D Young & Co, I’ve represented my clients in a number of high value opposition and appeal proceedings at the EPO especially in relation to major pharmaceutical products such as, Lipitor, Nexium, Abilify, Crestor and Sovaldi / Harvoni. I’m also qualified to represent clients in the Higher Courts as a patent attorney litigator.

I’m experienced in coordinating strategy between EPO oppositions and appeal proceedings, and corresponding litigation in other jurisdictions – both in Europe and the US. I’m also highly skilled at IP due diligence, having supported successful funding rounds for a number of SME clients, and product acquisitions for multinational clients.

I advise a range of clients in patent matters in the field of organic chemistry.  My practice encompasses drafting, filing and prosecution of patent applications with a particular emphasis on the preparation of infringement and validity opinions.  I also have a specific interest in IP protection for the pharmaceutical sector, including SPCs and regulatory data exclusivity.

Prior to joining D Young & Co, I worked as an in-house patent attorney at GlaxoSmithKline.  In 2006, I was seconded to the law firm Kenyon & Kenyon in New York.

Qualifications

  • BSc (Hons) in Chemistry, University of Sussex.
  • PhD in Organic Chemistry, University of Southampton.
  • Pfizer Organic Chemistry prize, University of Southampton.
  • Certificate in Intellectual Property Law, Queen Mary, University of London.
  • LLM in Intellectual Property Litigation, Nottingham Law School.
  • Patent Attorney Litigator.
  • European Patent Attorney 2001.
  • Chartered Patent Attorney 2002.
  • European Design Attorney.

Memberships

  • Chartered Institute of Patent Attorneys (CIPA).
  • European Patent Institute (epi).
Gallagher is at his best when devising infringement and validity opinions or handling contentious EPO proceedings.
IAM Patent 1000
Those seeking counsel on SPCs need look no further than Kirk Gallagher and Garreth Duncan.
IAM Patent 1000
Gallagher is a pharmaceuticals and nutrition ace.
IAM Patent 1000
IP Star 2017.
IP Stars (Managing IP)
Gallagher impresses in EPO proceedings.
IP Stars (Managing IP)
Kirk’s advice is well founded and timely. Where needed he doesn’t hesitate to obtain additional information to provide the best possible advice.
IP Stars (Managing IP)
Pharmaceuticals and organic chemistry whizz Kirk Gallagher put in a shift at GlaxoSmithKline.
IAM Patent 1000
Kirk Gallagher shines on SPC matters.
IAM Patent 1000
speechticktitle-abouttitle-careerstitle-clientstitle-contact-ustitle-hometitle-knowledge-banktitle-knowledge-banktitle-news-eventstitle-sectorstitle-servicestitle-team